Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception

Contraception

Volumn 91, Issue 3, 2015, Pages 185-192

  Hubacher, David ^a   Spector, Hannah ^b   Monteith, Charles ^b   Chen, Pai Lien ^a   Hart, Catherine ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b Planned Parenthood of Central North Carolina   (United States)

Author keywords

DMPA; IUD; LARC; Oral contraceptives; Subdermal contraceptive implant

Indexed keywords

ETONOGESTREL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTRACEPTION; CONTROLLED STUDY; COPPER INTRAUTERINE DEVICE; FEAR; FEMALE; HEALTH CARE COST; HEALTH HAZARD; HEALTH INSURANCE; HELP SEEKING BEHAVIOR; HUMAN; INJURY; LONG ACTING REVERSIBLE CONTRACEPTION; MULTICENTER STUDY; ORAL CONTRACEPTION; ORAL CONTRACEPTIVE USE; PAIN; PATIENT PARTICIPATION; PATIENT PREFERENCE; RANDOMIZED CONTROLLED TRIAL; SHORT ACTING REVERSIBLE CONTRACEPTION; SIDE EFFECT; UNPLANNED PREGNANCY; CONTRACEPTIVE BEHAVIOR; INSURANCE; PATIENT SELECTION; PREGNANCY; PROCEDURES; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; CONTRACEPTION; CONTRACEPTION BEHAVIOR; FEMALE; HUMANS; INSURANCE COVERAGE; PATIENT PREFERENCE; PATIENT SELECTION; PREGNANCY; PREGNANCY, UNPLANNED; YOUNG ADULT;

EID: 84923460867     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2014.11.006     Document Type: Article

References (33)

1. J. Trussell Contraceptive efficacy R. Hatcher, J. Trussell, A. Nelson, W. Cates, D. Kowal, M. Policar, Contraceptive Technology 20th Revised Ed. 2011 Ardent Media, Inc Atlanta, GA 779 863
2. WHO Family planning handbook: a global handbook for providers 2011 Department of Reproductive Health and Research Johns Hopkins Bloomberg School of Public Health Center for Communication Programs INFO Project Baltimore and Geneva [cited 2012 January 30; Available from: http://www.globalhandbook.org/ ]
3. W.D. Mosher, and J. Jones Use of contraception in the United States: 1982-2008 Vital Health Stat 23 2010 1 44
4. E.M. Stringer, C. Kaseba, J. Levy, M. Sinkala, R.L. Goldenberg, and B.H. Chi A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus Am J Obstet Gynecol 197 2007 144.e1 144.e8
5. P.J. Feldblum, J. Caraway, L. Bahamondes, M. El-Shafei, D. Quan Ha, and E. Morales Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation and disease ascertainment Contraception 72 2005 187 191
6. Preference Collaborative Review Group Patients' preferences within randomised trials: systematic review and patient level meta-analysis BMJ 337 2008 a1864
7. J.F. Peipert, Q. Zhao, J.E. Allsworth, E. Petrosky, T. Madden, and D. Eisenberg Continuation and satisfaction of reversible contraception Obstet Gynecol 117 2011 1105 1113
8. M. O'Neil-Callahan, J.F. Peipert, Q. Zhao, T. Madden, and G. Secura Twenty-four-month continuation of reversible contraception Obstet Gynecol 122 2013 1083 1091
9. C.R. Brewin, and C. Bradley Patient preferences and randomised clinical trials BMJ 299 1989 313 315
10. P. Brocklehurst Partially randomised patient preference trials Br J Obstet Gynaecol 104 1997 1332 1335
11. K.G. Cooper, A.M. Grant, and A.M. Garratt The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding Br J Obstet Gynaecol 104 1997 1367 1373
12. C. Chilvers, M. Dewey, K. Fielding, V. Gretton, P. Miller, and B. Palmer Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms BMJ 322 2001 772 775
13. D. Moher, S. Hopewell, K.F. Schulz, V. Montori, P.C. Gotzsche, and P.J. Devereaux CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials BMJ 340 2010 c869
14. L.B. Finer, A. Sonfield, and R.K. Jones Changes in out-of-pocket payments for contraception by privately insured women during implementation of the federal contraceptive coverage requirement Contraception 89 2014 97 102
15. Department of the Treasury Internal Revenue Service Department of Labor Employee Benefits Security Administration Department of Health and Human Services Centers for Medicare & Medicaid Services Coverage of certain preventive services under the Affordable Care Act. Final rules Fed Regist 78 2013 39869 39899
16. E.A. Micks, J.T. Jensen, and P.H. Bednarek The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study Contraception 90 2014 60 65
17. E. Espey, R.H. Singh, L. Leeman, T. Ogburn, K. Fowler, and H. Greene Misoprostol for intrauterine device insertion in nulliparous women: a randomized controlled trial Am J Obstet Gynecol 210 2014 208.e1 208.e5
18. R.H. Allen, D. Bartz, D.A. Grimes, D. Hubacher, and P. O'Brien Interventions for pain with intrauterine device insertion Cochrane Database Syst Rev 2009 CD007373 [Review]
19. R.H. Allen, C. Raker, and V. Goyal Higher dose cervical 2% lidocaine gel for IUD insertion: a randomized controlled trial Contraception 88 2013 730 736
20. K. Heinemann, C.L. Westhoff, D.A. Grimes, and S. Moehner Intrauterine devices and the risk of uterine perforations: final results from the EURAS-IUD study Obstet Gynecol 123 Suppl. 1 2014 3S
21. A.M. Gomez, and J.B. Clarks The relationship between contraceptive features preferred by young women and interest in IUDs: an exploratory analysis Perspect Sex Reprod Health 46 2014 157 163
22. C.C. Harper, J.T. Henderson, T.R. Raine, S. Goodman, P.D. Darney, and K.M. Thompson Evidence-based IUD practice: family physicians and obstetrician-gynecologists Fam Med 44 2012 637 645
23. T. Beeson, S. Wood, B. Bruen, D.G. Goldberg, H. Mead, and S. Rosenbaum Accessibility of long-acting reversible contraceptives (LARCs) in Federally Qualified Health Centers (FQHCs) Contraception 89 2014 91 96
24. M.A. Biggs, A. Arons, R. Turner, and C.D. Brindis Same-day LARC insertion attitudes and practices Contraception 88 2013 629 635
25. M.C. Fox, J. Oat-Judge, K. Severson, R.M. Jamshidi, R.H. Singh, and R. McDonald-Mosley Immediate placement of intrauterine devices after first and second trimester pregnancy termination Contraception 83 2011 34 40
26. M. Cremer, K.A. Bullard, R.M. Mosley, C. Weiselberg, M. Molaei, and V. Lerner Immediate vs. delayed post-abortal copper T 380A IUD insertion in cases over 12 weeks of gestation Contraception 83 2011 522 527
27. I. Mavranezouli The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline Hum Reprod 23 2008 1338 1345
28. D.G. Foster, M.A. Biggs, J. Malvin, M. Bradsberry, P. Darney, and C.D. Brindis Cost-savings from the provision of specific contraceptive methods in 2009 Womens Health Issues 23 2013 e265 e271
29. J. Trussell, N. Henry, F. Hassan, A. Prezioso, A. Law, and A. Filonenko Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception Contraception 87 2013 154 161
30. J.F. Peipert, T. Madden, J.E. Allsworth, and G.M. Secura Preventing unintended pregnancies by providing no-cost contraception Obstet Gynecol 120 2012 1291 1297
31. B. Winner, J.F. Peipert, Q. Zhao, C. Buckel, T. Madden, and J.E. Allsworth Effectiveness of long-acting reversible contraception N Engl J Med 366 2012 1998 2007
32. S. Ricketts, G. Klingler, and R. Schwalberg Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women Perspect Sex Reprod Health 46 2014 125 132
33. L.B. Finer, and M.R. Zolna Shifts in intended and unintended pregnancies in the United States, 2001-2008 Am J Public Health 104 Suppl. 1 2014 S43 S48